This discrepancy is likely due to the fact that they used an inducible liver-specific MYC oncogene transgenic model and mice were fed a methionine-choline-deficient diet to induce NAFLD and HCC, while our mouse model presents a systemic induction of NAFLD and HCC through diet alone. The gene discussed is MYC; the disease is metabolic dysfunction-associated steatotic liver disease.